ArticleCancers2025

Prognostic Role of Adaptive Immune Microenvironment in Patients with High-Risk Myelodysplastic Syndromes Treated with 5-Azacytidine.

Zoi Tsakiraki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.